VTE risk high in cancer patients receiving immune checkpoint inhibitors
Is a cheap ‘universal’ coronavirus vaccine on the way?
26 April 2021Why some people don’t experience vaccine side effects, and why it’s not a problem
26 April 2021VTE risk high in cancer patients receiving immune checkpoint inhibitors
(HealthDay)—Patients with cancer receiving immune checkpoint inhibitor treatment are at high risk for thromboembolism, especially venous thromboembolism (VTE), according to a study published online March 25 in Blood.
